PRN.TSX
Profound Medical Corp.

0
Mkt Cap
$253.69M
Volume
18,557.00
52W High
$12.40
52W Low
$5.23
PE Ratio
-3.55
PRN.TSX Fundamentals
Price
$6.99
Prev Close
$7.06
Open
$7.00
50D MA
$9.51
Beta
0.88
Avg. Volume
14,667.63
EPS (Annual)
-$1.97
P/B
2.79
Rev/Employee
$138,849.08
$250.20
Loading...
Loading...

About

Profound Medical Corp. is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the ablation of diseased tissue utilizing its platform technologies. The firm’s product, the TULSA-PRO system, combines real-time MRI, robotically driven transurethral sweeping action/thermal ultrasound, and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It is also focused on developing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. The company was founded on June 13, 2008 and is headquartered in Mississauga, Canada.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
162

Frequently Asked Questions

What is Market Cap of Profound Medical Corp?
What is the 52-week high for Profound Medical Corp?
What is the 52-week low for Profound Medical Corp?
What is Profound Medical Corp stock price today?
What was Profound Medical Corp stock price yesterday?
What is the PE ratio of Profound Medical Corp?
What is the Price-to-Book ratio of Profound Medical Corp?
What is the 50-day moving average of Profound Medical Corp?
How many employees does Profound Medical Corp have?

Latest PRN.TSX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.